Diabetes Mellitus and Hypertension

  • Daniel Caruso
  • Kwame Osei
Part of the Contemporary Internal Medicine book series (COIM, volume 3)

Abstract

The relationship between diabetes mellitus (DM) and hypertension has been recognized since the 1920’s.1–3 Diabetics are at increased risk for atherosclerotic complications and hypertension increases this risk. It is now becoming evident that complications associated with diabetes, including nephropathy and retinopathy, are related not only to the duration of diabetes and degree of diabetic control but also to the presence, duration and severity of hypertension. Furthermore, the relationship of hypertension to diabetes differs somewhat between type I DM (insulin-dependent [IDDM], juvenile onset, ketosis-prone) and type II DM (non-insulin-dependent [NIDDM], adult onset, nonketotic) and could modulate the prognosis of diabetes in the respective diabetic groups. The case summaries of three diabetic patients discussed below illustrate important differences and similarities in the etiology and natural history of hypertension in diabetic patients.

Keywords

Diabetic Nephropathy Diabetic Retinopathy Urinary Albumin Exchangeable Sodium Renal Hypertension 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Hitzenberger K: Uber den Blutdruck bei Diabetes mellitus. Wien Arch Inn Med. 1921;2:461.Google Scholar
  2. 2.
    Maranon G: Uber hypertonic und Zuckerkrankheit. Zentralbl Med. 1922;43:169–176.Google Scholar
  3. 3.
    Major SG: Blood pressure in diabetes mellitus: A statistical study. Arch Intern Med. 1929;44:781–797.CrossRefGoogle Scholar
  4. 4.
    National Diabetes Data Group: Summary, in National Diabetes Data Group (ed): Diabetes in America. US Dept of Health and Human Services; 1985, pp 1-6.Google Scholar
  5. 5.
    Hasslacher C, Ritz E, Tschope W, et al: Hypertension in diabetes mellitus. Kidney Int Suppl. 1988;25:S133–S137.PubMedGoogle Scholar
  6. 6.
    Ferriss JB, O’Hare JA, Cole M, et al: Blood pressure in diabetic patients: relationships with exchangeable sodium and renin activity. Diabetic Nephropathy. 1986;5:27–30.Google Scholar
  7. 7.
    Christlieb AR: Treating hypertension in the patient with diabetes mellitus. Med Clin North Am. 1982;66:1373–1388.PubMedGoogle Scholar
  8. 8.
    Krolewski AS, Canessa M, Warram JH, et al: Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med. 1988;318:140–145.PubMedCrossRefGoogle Scholar
  9. 9.
    Feldt-Rassmussen B, Mathiesen ER, Deckert T: Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes. Lancet. 1986;2:1300–1304.CrossRefGoogle Scholar
  10. 10.
    Luetscher JA, Kraemer FB: Microalbuminuria and increased plasma prorenin. Prevalence in diabetics followed up for four years. Arch Intern Med. 1988;148:937–941.Google Scholar
  11. 11.
    Mathiesen ER, Hommel E, Olsen UB, et al: Elevated urinary prostaglandin excretion and the effect of indomethacin on renal function in incipient diabetic nephropathy. Diabetic Med. 1988;5:145–149.PubMedCrossRefGoogle Scholar
  12. 12.
    Christlieb AR, Kalding A, D’Elia JA: Plasma renin activity and hypertension in diabetes mellitus. Diabetes. 1976;25:969–974.PubMedCrossRefGoogle Scholar
  13. 13.
    Mangili R, Bending JJ, Scott G, et al: Increased sodium-lithium transport activity in red cells of patients with insulin-dependent diabetes mellitus. N Engl J Med. 1988;313:146–150.CrossRefGoogle Scholar
  14. 14.
    Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, et al: Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia. 1989;32:219–226.CrossRefGoogle Scholar
  15. 15.
    Mbanya JC, Thomas TH, Wilkinson R, et al: Hypertension and hyperinsulinaemia: A relation in diabetes but not essential hypertension. Lancet. 1988;1:733–734.PubMedCrossRefGoogle Scholar
  16. 16.
    Ferrannini E, Buzzigoli G, Bonadonna R, et al: Insulin resistance in essential hypertension. N Engl J Med. 1987;317:350–357.PubMedCrossRefGoogle Scholar
  17. 17.
    DeFronzo RA: The effect of insulin on renal sodium metabolism. Diabetologia. 1981;21:165–171.PubMedCrossRefGoogle Scholar
  18. 18.
    Eggers PW: Effect of transplantation on the Medicare End Stage Renal Disease Program. N Engl J Med. 1988;318:223–229.PubMedCrossRefGoogle Scholar
  19. 19.
    Cowie CC, Port FK, Wolfe RA, et al: Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. N Engl J Med. 1989;321:1074–1079.PubMedCrossRefGoogle Scholar
  20. 20.
    Nelson RG, Pettitt DJ, Carraher MJ, et al: Effect of proteinuria on mortality in NIDDM. Diabetes. 1988;37:1499–1504.PubMedCrossRefGoogle Scholar
  21. 21.
    Pugh JA, Stern MP, Haffner SM, et al: Excess incidence of treatment of end-stage renal disease in Mexican Americans. Am J Epidemiol. 1988;127:135–144.PubMedGoogle Scholar
  22. 22.
    Parving HH, Hommel E, Mathiesen E, et al: Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin dependent diabetes. Br Med J Clin Res. 1988;296:156–160.CrossRefGoogle Scholar
  23. 23.
    Mogensen CE: Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med. 1984;310:356–360.PubMedCrossRefGoogle Scholar
  24. 24.
    Mogensen CE, Christensen CK: Predicting diabetic nephropathy in insulin-dependent diabetes mellitus. N Engl J Med. 1984;311:89–93.PubMedCrossRefGoogle Scholar
  25. 25.
    Luetscher JA, Kraemer FB, Wilson DM: Prorenin and vascular complications of diabetes. Am J Hypertens. 1989;2:382–386.PubMedGoogle Scholar
  26. 26.
    Barnett AH, Dallinger K, Jennings P, et al: Microalbuminuria and diabetic retinopathy. Lancet. 1985;1:53–54.PubMedCrossRefGoogle Scholar
  27. 27.
    Parving HH, Smidt UM, Andersen AR, et al: Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet. 1983;1:1775–1779.Google Scholar
  28. 28.
    The Working Group on Hypertension in Diabetes. Statement on hypertension in diabetes mellitus. Arch Intern Med. 1987;147:830–842.CrossRefGoogle Scholar
  29. 29.
    Parving HH, Larsen M, Hommel E, et al: Effect of antihypertensive treatment on blood-retinal barrier permeability to fluorescein in hypertensive type 1 (insulin-dependent) diabetic patients with background retinopathy. Diabetologia. 1989;32:440–444.PubMedCrossRefGoogle Scholar
  30. 30.
    Kaplan NM: Critique of recommendations from Working Group on Hypertension in Diabetes. Am J Kidney Dis. 1989;13:38–40.PubMedGoogle Scholar
  31. 31.
    Harnet P, Kalant N, Ross SA, et al: Recommendations from the Canadian Hypertension Society Consensus Conference on Hypertension and Diabetes. Can Med Assoc J. 1988;139:1059–1062.Google Scholar
  32. 32.
    Zucchelli P, Zuccala A, Sturani A: Glomerular dysfunction in diabetic nephropathy. Postgrad Med J. 1988;64(Suppl 3):22–30; discuss.PubMedGoogle Scholar
  33. 33.
    Hommel E, Parving HH, Mathiesen E, et al: Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy. British Med J. 1986;293:467–470.CrossRefGoogle Scholar
  34. 34.
    Bjorck S, Nyperg G, Mulec H, et al: Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. BMJ. 1986;293:471–474.PubMedCrossRefGoogle Scholar
  35. 35.
    Christensen CK: Abnormal albuminuria and blood pressure rise in incipient diabetic nephropathy induced by exercise. Kidney Int. 1984;25:819–823.PubMedCrossRefGoogle Scholar
  36. 36.
    Christensen CK, Mogensen CE: Effect of antihypertensive treatment on progression of incipient diabetic nephropathy. Hypertension. 1958;7:9–13.Google Scholar
  37. 37.
    Friedman PJ, Dunn PJ, Jury DR: Metoprolol and albumin excretion in diabetes. Lancet. 1986;2:43.Google Scholar
  38. 38.
    Marre M, Leblanc H, Suarez L, et al: Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria. British Med J. 1987;294:1448–1452.CrossRefGoogle Scholar
  39. 39.
    Viberti GC, Bilous RW, Mackintosh D, et al: Long-term correction of hyperglycemia and progression of renal failure in insulin-dependent diabetes. British Med J. 1983;286:598–602.CrossRefGoogle Scholar
  40. 40.
    Christiansen JS, Parving HH: The effect of short term strict metabolic control on albuminuria in insulin-dependent diabetics with normal kidney function and diabetic neuropathy. Diabetic Nephropathy. 1984;3:127–129.Google Scholar
  41. 41.
    Feldt-Rassmussen B, Mathiesen ER, Hegedus L, et al: Kidney function during 12 months of strict metabolic control instrument insulin-dependent diabetic patients with incipient nephropathy. N Engl J Med. 1986;314:665–670.CrossRefGoogle Scholar
  42. 42.
    Deckert T, Lauritzen T, Parving HH, et al: Effect of two years of strict metabolic functions in long term insulin-dependent diabetics. Diabetic Nephropathy. 1984;3:6–10.Google Scholar

Copyright information

© Springer Science+Business Media New York 1991

Authors and Affiliations

  • Daniel Caruso
  • Kwame Osei

There are no affiliations available

Personalised recommendations